Autolus Therapeutics News

Express News | Autolus Therapeutics Says It Will Reveal Three Abstracts To Be Presented At European Hematology Association (EHA) Congress

BenzingaJun 14 07:14 ET

Autolus Therapeutics to Present Three Clinical Data Updates on Obecabtagene Autoleucel (Obe-cel) in Relapsed/refractory (R/r) B-Cell Acute Lymphoblastic Leukemia (ALL) Patients at the 2024 European Hematology Association (EHA) Congress

LONDON, June 14, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces three abstracts to be

GlobeNewswireJun 14 07:00 ET

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading

European equities traded in the US as American depositary receipts were moving sharply higher late Wednesday morning, rising 1.59% to 1,445.87 on the S&P Europe Select ADR Index. From continental Euro

MT NewswiresJun 12 11:20 ET

European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending sharply lower late Tuesday morning, falling 1.34% to 1,420.05 on the S&P Europe Select ADR Index. From continental Euro

MT NewswiresJun 11 11:11 ET

Analysts' Top Healthcare Picks: Autolus Therapeutics (AUTL), Affimed (AFMD)

TipRanksJun 3 06:20 ET

Autolus Therapeutics Presents Longer-term Follow-up and Additional Data Analysis of Pivotal Phase 2 FELIX Study of Obe-cel for Adult R/r B-ALL in an Oral Presentation at ASCO

The majority of patients that responded to obe-cel showed durable responses with the potential for a long-term plateau of survival outcomes40% patients are in ongoing remission without subsequent stem cell transplant

GlobeNewswireMay 31 08:00 ET

Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

Tech stocks led European equities traded in the US as American depositary receipts modestly higher Thursday morning, rising 0.4% to 1,428.1 on the S&P Europe Select ADR Index. From continental Europe,

MT NewswiresMay 23 11:13 ET

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were trending modestly higher late Tuesday morning, rising 0.32% to 1,431.33 on the S&P Europe Select ADR Index. From continental Eur

MT NewswiresMay 21 11:06 ET

Autolus Therapeutics: A Strong Buy on Promising Obe-cel Developments and Strategic Readiness

TipRanksMay 20 08:27 ET

Buy Rating Affirmed: Autolus Therapeutics' Strategic Position and Upcoming Catalysts Promise Upside Potential

TipRanksMay 20 06:17 ET

Earnings Call Summary | Autolus Therapeutics(AUTL.US) Q1 2024 Earnings Conference

The following is a summary of the Autolus Therapeutics Plc (AUTL) Q1 2024 Earnings Call Transcript:Financial Performance:Autolus Therapeutics reported a Q1 2024 operating loss of $38.8 million, a slig

moomoo AIMay 17 19:39 ET · Conference Call

Autolus Therapeutics | 10-Q: Quarterly report

SEC announcementMay 17 16:44 ET · Announcements

Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) fell sharply during Friday's session after the company reduced its dividend and said it expects third-quarter and fourth-quarter results

BenzingaMay 17 14:18 ET

Express News | Needham Reiterates Buy on Autolus Therapeutics, Maintains $9 Price Target

BenzingaMay 17 13:42 ET

Autolus Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 100.45% Needham → $9 Reiterates Buy → Buy 04/12/2024 100.45% Needham → $9 Reiterates Buy → Buy

BenzingaMay 17 13:41 ET

Analysts Are Bullish on Top Healthcare Stocks: Autolus Therapeutics (AUTL), Citius Pharmaceuticals (CTXR)

TipRanksMay 17 13:40 ET

Autolus Therapeutics Plc (AUTL) Q1 2024 Earnings Call Transcript

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2024 Earnings Conference Call May 17, 2024 8:30 AM ET

Earnings Call TranscriptsMay 17 12:55 ET

Autolus Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.

Autolus Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.

BenzingaMay 17 12:52 ET

Express News | Autolus Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results

BenzingaMay 17 12:52 ET

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading

European equities traded in the US as American depositary receipts were trending modestly higher late Friday morning, rising 0.29% to 1,426.43 on the S&P Europe Select ADR Index. The index is set to c

MT NewswiresMay 17 11:06 ET